B
Biogenetics
Focuses its activity to the development of products and services based on genomics, proteomics and metabolomics - between others sciencies- specially for the agrifood, farming and biodiversity…
About Biogenetics
Biogenetics is a pioneering startup that addresses critical issues in food safety, conservation genetics, and biotechnology. The company operates in the biotechnology and food safety market, serving a diverse range of clients including food producers, conservationists, and research institutions.
Biogenetics tackles the rampant problem of food fraud, particularly in the olive oil industry where over 89% of traded olive oil is fraudulent. The company provides advanced diagnostic kits, such as GenExpress, which detect harmful bacteria like Campylobacter spp. in food samples, ensuring food safety and preventing contamination along the food chain.
In the realm of conservation genetics, Biogenetics offers solutions like MolECOL and PROGENIEX. MolECOL helps determine the threat levels faced by endangered species, such as the European mink, and plays a crucial role in the success of preservation programs. PROGENIEX focuses on protecting and improving indigenous animal populations, which are vital for preserving cultural and rural heritage.
The company also delves into metagenomics, using DNA sequencing to identify beneficial microorganisms in various environments. This technology aids in controlling plant pathogens and assessing soil productivity, which is essential for sustainable agriculture.
Biogenetics' business model revolves around selling diagnostic kits, genetic analysis tools, and laboratory supplies such as PCR tubes and micropipette tips. The company generates revenue through direct sales to food producers, research institutions, and conservation organizations. By providing these essential tools and services, Biogenetics ensures food safety, aids in the conservation of endangered species, and supports sustainable agricultural practices.
Source: Dealroom company dataAt a glance
- Status
- Closed
- Founded
- 2013
- Headquarters
- Vitoria, Spain
- Employees
- 1
- Open positions
- None listed
- Dealroom signal
- 0.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Food Processing, Biotechnology, Agritech, Molecular, Primary Production, Hard Tech, Horizon Europe, proteomics, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Jan 2018 | $40K | — | Provincial Council of Álava | — |
| GRANT✓Other financing | Dec 2017 | $55K | — | European Innovation Council | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Biogenetics is 120 monthly website visits, down 87.6% over the last three months. Biogenetics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Basque Government
Gestión de Capital Riesgo del País Vasco
European Innovation Council
Provincial Council of Álava
Other known investors1 additional known investor
BIC Araba
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biogenetics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biogenetics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







